# EDGAR Filing Document

**Accession Number:** 0001930313
**File Stem:** 0001641172-25-015572
**Filing Date:** 2025-6
**Character Count:** 60887
**Document Hash:** 54d9a2c559dcedcd3f164bc993dd869b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-015572.hdr.sgml**: 20250618

**ACCESSION NUMBER**: 0001641172-25-015572

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250613

**ITEM INFORMATION**: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250618

**DATE AS OF CHANGE**: 20250618

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SBC Medical Group Holdings Inc
- **CENTRAL INDEX KEY:** 0001930313
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 881263511
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41462
- **FILM NUMBER:** 251056781

**BUSINESS ADDRESS:**
- **STREET 1:** 200 SPECTRUM CENTER DR.
- **STREET 2:** SUITE 300
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92618
- **BUSINESS PHONE:** 9495930250

**MAIL ADDRESS:**
- **STREET 1:** 200 SPECTRUM CENTER DR.
- **STREET 2:** SUITE 300
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92618

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Pono Capital Two, Inc.
- **DATE OF NAME CHANGE:** 20220520

?xml version='1.0' encoding='ASCII'?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION** **WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): June 13, 2025**

**SBC MEDICAL GROUP HOLDINGS INCORPORATED**

**(Exact name of Registrant as Specified in Its Charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41462** | **88-1192288** |
| **(State or Other Jurisdiction<br> of Incorporation)** | **(Commission<br> File Number)** | **(IRS Employer<br> Identification No.)** |

---

---

| | |
|:---|:---|
| **200 Spectrum Center Dr. STE 300** |  |
| **Irvine, CA** | **92618** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code: 949-593-0250**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br> Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.0001 par value per share | SBC | The Nasdaq Stock Market LLC |
| Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share | SBCWW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**

As described under Item 5.07 of this Current Report on Form 8-K (the "Report"), SBC Medical Group Holdings Incorporated (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting") on June 13, 2025. At the Annual Meeting, upon the recommendation of the Company's board of directors, the Company's stockholders approved an the adoption of an amendment and restatement of the Company's certificate of incorporation (the "Amended and Restated Charter"), which will declassify the board of directors such that the terms of all the Company's current directors will end at the 2026 annual meeting of stockholders, and all director nominees will stand for election annually at and after the 2026 annual meeting of stockholders. The Amended and Restated Charter will become effective upon the filing thereof with the Secretary of State of the State of Delaware.

The foregoing description of the Amended and Restated Charter does not purport to be complete and is qualified in its entirety by reference to the full text of Exhibit 3.1 to this Report, which is incorporated herein by reference.

**Item 5.07 Submission of Matters to a Vote of Security Holders.** 

Of the 103,611,251 shares of the Company's common stock outstanding as of the record date of April 21, 2025, 92,710,439 shares were represented at the Annual Meeting, either by proxy or by attending the meeting, constituting a quorum. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:

1) **Proposal 1**. At the Annual Meeting, the vote to elect two directors to serve three-year terms expiring in 2028, at the annual meeting of stockholders, was as follows. However, because Proposal 3 (relating to the declassification of the Company's board of directors) was approved, all of the Company's directors, including the members of the class elected at the Annual Meeting, will serve until the 2026 annual meeting of stockholders, at which point they may be renominated for a further one year term.

---

| | | | |
|:---|:---|:---|:---|
|  | FOR | WITHHELD | BROKER<br> NON-VOTE |
| Ken Edahiro | 92,710,188 | 251 | 0 |
| Mike Sayama | 92,699,163 | 11,276 | 0 |

---

2) **Proposal 2.** At the Annual Meeting, the vote to ratify the appointment of MaloneBailey, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was as follows:

<u>FOR</u> <u>AGAINST</u> <u>ABSTAIN</u> <br> <u>92,710,039</u> <u>100</u> <u>300</u>

3) **Proposal 3.** At the Annual Meeting, the adoption of an amendment and restatement of the Company's Current Charter, to declassify the board of directors such that the terms of all the Company's current directors will end at the 2026 annual meeting of stockholders, and all director nominees will stand for election annually at and after the 2026 annual meeting of stockholders, was as follows:

---

| | | | |
|:---|:---|:---|:---|
| FOR | AGAINST | ABSTAIN | BROKER<br> NON-VOTE |
| 92,710,188 | 251 | 0 | 0 |

---

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits

<u>Exhibit</u> <u>Description</u> <br> 3.1 [Amended and Restated Certificate of Incorporation](ex3-1.htm) <br> 104 The cover page of this Current Report on Form 8-K, formatted in inline XBRL.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **SBC MEDICAL GROUP HOLDINGS INCORPORATED** | **SBC MEDICAL GROUP HOLDINGS INCORPORATED** |
| Date: | June 18, 2025 | By: | */s/ Yuya Yoshida* |
|  |  |  | Yuya Yoshida |
|  |  |  | Chief Financial Officer |

---

## Exhibit 3.1

**Exhibit 3.1**

FIFTH AMENDED AND RESTATED<br> CERTIFICATE OF INCORPORATION<br> OF<br> SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated (the "Corporation") a corporation organized and existing under the Delaware General Corporation Law, hereby certifies as follows:

FIRST: The name of the corporation is SBC Medical Group Holdings Incorporated.

SECOND: The date of filing of the original Certificate of Incorporation of the Corporation, under the original entity name PONO CAPITAL TWO, INC., with the Secretary of State of the State of Delaware is March 11, 2022 (the "Original Certificate").

THIRD: The Original Certificate was amended and restated in its entirety by the Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware on May 17, 2022 (the "Amended and Restated Certificate").

FOURTH: The Amended and Restated Certificate was amended and restated in its entirety by the Second Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware on August 2, 2022 (the "Second Amended and Restated Certificate").

FIFTH: The Second Amended and Restated Certificate was amended and restated in its entirety by the Third Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware on August 5, 2022 (the "Third Amended and Restated Certificate").

SIXTH: The Third Amended and Restated Certificate was amended by the Amendment to the Third Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware on May 8, 2023.

SEVENTH: The Third Amended and Restated Certificate was amended and restated by the Fourth Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware on September 17, 2024 (the "Current Certificate").

This Fifth Amended and Restated Certificate of Incorporation amends and restates the Current Certificate in its entirety.

SIXTH: This Fifth Amended and Restated Certificate of Incorporation has been duly approved and adopted by the Board of Directors of the Corporation on May 12, 2025 and by the stockholders of the Corporation on June 13, 2025, in accordance with the provisions of Sections 141, 222, 242 and 245 of the General Corporation Law of the State of Delaware.

SEVENTH: the Current Certificate is hereby amended and restated in its entirety to provide as follows:

Section 1. <u>Name</u>. The name of the corporation is SBC Medical Group Holdings Incorporated (the "Corporation").

Section 2. <u>Registered Office and Agent</u>. The name and address of the registered agent of the Corporation in the State of Delaware is Corporate Creations Network Inc., Corporate Creations Network Inc., 1521 Concord Pike, Suite 201, Wilmington, DE 19803, New Castle County, or such other agent and address as the Board of Directors of the Corporation (the "Board") shall from time to time select.

Section 3. <u>Purpose and Business</u>. The purpose of the Corporation is to engage in any lawful act or activity for which corporations may now or hereafter be organized under the Delaware General Corporation Law (the "DGCL"), including, but not limited to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Corporation may at any time exercise such rights, privileges, and powers, when not inconsistent with
the purposes and object for which this Corporation is organized.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Corporation shall have the power to have succession by its corporate name in perpetuity, or until
dissolved and its affairs wound up according to law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Corporation shall have the power to sue and be sued in any court of law or equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The Corporation shall have the power to make contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The Corporation shall have the power to hold, purchase and convey real and personal estate and to mortgage
or lease any such real and personal estate with its franchises. The power to hold real and personal estate shall include the power to
take the same by devise or bequest in the State of Delaware, or in any other state, territory or country.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) The Corporation shall have the power to appoint such officers and agents as the affairs of the Corporation
shall require and allow them suitable compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) The Corporation shall have the power to make bylaws not inconsistent with the constitution or laws of
the United States, or of the State of Delaware, for the management, regulation and government of its affairs and property, the transfer
of its stock, the transaction of its business and the calling and holding of meetings of stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) The Corporation shall have the power to wind up and dissolve itself, or be wound up or dissolved.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The Corporation shall have the power to adopt and use a common seal or stamp, or to not use such seal
or stamp and if one is used, to alter the same. The use of a seal or stamp by the Corporation on any corporate documents is not necessary.
The Corporation may use a seal or stamp, if it desires, but such use or non-use shall not in any way affect the legality of the document.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) The Corporation shall have the power to borrow money and contract debts when necessary for the transaction
of its business, or for the exercise of its corporate rights, privileges or franchises, or for any other lawful purpose of its incorporation;
to issue bonds, promissory notes, bills of exchange, debentures and other obligations and evidence of indebtedness, payable at a specified
time or times, or payable upon the happening of a specified event or events, whether secured by mortgage, pledge or otherwise, or unsecured,
for money borrowed, or in payment for property purchased, or acquired, or for another lawful object.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) The Corporation shall have the power to guarantee, purchase, hold, sell, assign, transfer, mortgage, pledge

corporation or corporations in the State of Delaware, or any other state or government and, while the owner of such stock, bonds, securities
or evidence of indebtedness, to exercise all the rights, powers and privileges of ownership, including the right to vote, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) The Corporation shall have the power to purchase, hold, sell and transfer shares of its own capital stock
and use therefore its capital, capital surplus, surplus or other property or fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) The Corporation shall have the power to conduct business, have one or more offices and hold, purchase,
mortgage and convey real and personal property in the State of Delaware and in any of the several states, territories, possessions and
dependencies of the United States, the District of Columbia and in any foreign country.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) The Corporation shall have the power to do all and everything necessary and proper for the accomplishment
of the objects enumerated in this Fifth Amended and Restated Certificate of Incorporation (this "Fifth Amended Certificate"),
or any amendments thereof, or necessary or incidental to the protection and benefit of the Corporation and, in general, to carry on any
lawful business necessary or incidental to the attainment of the purposes of the Corporation, whether or not such business is similar
in nature to the purposes set forth in this Fifth Amended Certificate, or any amendment thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) The Corporation shall have the power to make donations for the public welfare or for charitable, scientific
or educational purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) The Corporation shall have the power to enter partnerships, general or limited, or joint ventures, in
connection with any lawful activities.

Section 4. <u>Capital Stock</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Classes and Number of Shares</u>. The total number of shares of all classes of stock, which the Corporation
shall have authority to issue shall be Four Hundred Million (400,000,000) shares of common stock, par value of $0.0001 per share (the
"Common Stock") and Twenty Million (20,000,000) shares of preferred stock, par value of $0.0001 per share (the "Preferred
Stock").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Powers and Rights of Common Stock</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Preemptive Right</u>. No shareholders of the Corporation holding Common Stock shall have any preemptive
or other right to subscribe for any additional unissued or treasury shares of stock or for other securities of any class, or for rights,
warrants or options to purchase stock, or for scrip, or for securities of any kind convertible into stock or carrying stock purchase warrants
or privileges unless so authorized by the Corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Voting Rights and Powers</u>. With respect to all matters upon which stockholders are entitled to vote
or to which stockholders are entitled to give consent, the holders of the outstanding shares of the Common Stock shall be entitled to
cast thereon one (1) vote in person or by proxy for each share of the Common Stock standing in his/her name.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <u>Dividends and Distributions</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) <u>Cash Dividends</u>. Subject to the rights of holders of Preferred Stock, holders of Common Stock shall
be entitled to receive such cash dividends as may be declared thereon by the Board from time to time out of assets or funds of the Corporation
legally available therefore; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) <u>Other Dividends and Distributions</u>. The Board may issue shares of the Common Stock in the form of
a distribution or distributions pursuant to a stock dividend or split-up of the shares of the Common Stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) <u>Other Rights</u>. Except as otherwise required by the DGCL and as may otherwise be provided in this
Fifth Amended Certificate, each share of the Common Stock shall have identical powers, preferences and rights, including rights in liquidation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Classes of Preferred Stock</u>. The powers, preferences, rights, qualifications, limitations and restrictions
pertaining to the Preferred Stock, or any series thereof, shall be such as may be fixed, from time to time, by the Board in its sole discretion,
authority to do so being hereby expressly vested in the Board. The authority of the Board with respect to each such series of Preferred
Stock will include, without limiting the generality of the foregoing, the determination of any or all of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The number of shares of any series and the designation to distinguish the shares of such series from the
shares of all other series;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the voting powers, if any, of the shares of such series and whether such voting powers are full or limited;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) the redemption provisions, if any, applicable to such series, including the redemption price or prices
to be paid;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) whether dividends, if any, will be cumulative or noncumulative, the dividend rate or rates of such series
and the dates and preferences of dividends on such series;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) the rights of such series upon the voluntary or involuntary dissolution of, or upon any distribution of
the assets of, the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) the provisions, if any, pursuant to which the shares of such series are convertible into, or exchangeable
for, shares of any other class or classes or of any other series of the same or any other class or classes of stock, or any other security,
of the Corporation or any other corporation or other entity, and the rates or other determinants of conversion or exchange applicable
thereto;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) the right, if any, to subscribe for or to purchase any securities of the Corporation or any other corporation
or other entity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) the provisions, if any, of a sinking fund applicable to such series; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) any other relative, participating, optional or other powers, preferences or rights, and any qualifications,
limitations or restrictions thereof, of such series.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Issuance of the Common Stock and the Preferred Stock</u>. The Board may from time to time authorize
by resolution the issuance of any or all shares of the Common Stock and the Preferred Stock herein authorized in accordance with the terms
and conditions set forth in this Fifth Amended Certificate for such purposes, in such amounts, to such persons, corporations, or entities,
for such consideration and in the case of the Preferred Stock, in one or more series, all as the Board in its discretion may determine
and without any vote or other action by the stockholders, except as otherwise required by law. The Board, from time to time, also may
authorize, by resolution, options, warrants and other rights convertible into Common or Preferred stock (collectively "securities").
The securities must be issued for such consideration, including cash, property, or services, as the Board may deem appropriate, subject
to the requirement that the value of such consideration be no less than the par value of the shares issued. Any shares issued for which
the consideration so fixed has been paid or delivered shall be fully paid stock and the holder of such shares shall not be liable for
any further call or assessment or any other payment thereon, provided that the actual value of such consideration is not less that the
par value of the shares so issued. The Board may issue shares of the Common Stock in the form of a distribution or distributions pursuant
to a stock dividend or split-up of the shares of the Common Stock only to the then holders of the outstanding shares of the Common Stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Cumulative Voting</u>. Except as otherwise required by applicable law, there shall be no cumulative
voting on any matter brought to a vote of stockholders of the Corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>One Class</u>. Except as otherwise required by the DGCL, this Fifth Amended Certificate, or any designation
for a class of Preferred Stock (which may provide that an alternate vote is required), (i) all shares of capital stock of the Corporation
shall vote together as one class on all matters submitted to a vote of the shareholders of the Corporation; and (ii) the affirmative vote
of a majority of the voting power of all outstanding shares of voting stock entitled to vote in connection with the applicable matter
shall be required for approval of such matter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>Section 242(b)(2) Election</u>. For the avoidance of doubt, the intent of Section 4(f) is, and the
operation of Section 4(f) shall be, that, without limitation, (i) the number of authorized shares of Common Stock, may be increased or
decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the stock
of the Corporation entitled to vote irrespective of Section 242(b)(2) of the DGCL, with no vote of any holders of a particular class of
stock, voting as a separate class, being required; and (ii) unless otherwise set forth in a certificate of designations for the applicable
class of Preferred Stock, the number of authorized shares of any class of Preferred Stock may be increased or decreased (but not below
the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the stock of the Corporation entitled
to vote irrespective of Section 242(b)(2) of the DGCL, with no vote of any holders of a particular class of stock, voting as a separate
class, being required.

Section 5. <u>Adoption of Bylaws</u>. In the furtherance and not in limitation of the powers conferred by statute and subject to Section 6, the Board is expressly authorized to adopt, repeal, rescind, alter or amend in any respect the bylaws of the Corporation (the "Bylaws").

Section 6. <u>Shareholder Amendment of Bylaws</u>. Notwithstanding Section 5, the Bylaws may also be adopted, repealed, rescinded, altered or amended in any respect by the stockholders of the Corporation, but only by the affirmative vote of the holders of a majority of the voting power of all outstanding shares of voting stock, regardless of class and voting together as a single voting class.

Section 7. <u>Board of Directors</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The business and affairs of the Corporation shall be managed by and under the direction of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The number of directors of the Corporation, other than those who may be elected by the holders of one
or more series of the Preferred Stock voting separately by class or series, shall be fixed from time to time exclusively by the Board
pursuant to a resolution adopted by a majority of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The term of office of all directors serving as of the effective date of this Certificate of Incorporation
shall expire at the 2026 annual meeting of stockholders of the Corporation. At each succeeding annual meeting of the stockholders of the
Corporation, each of the successors elected to replace the class of directors whose term expires at that annual meeting shall be elected
for a one-year term or until the election and qualification of their respective successors in office, subject to their earlier death,
resignation or removal. Subject to Section 7(g), a director shall hold office until the annual meeting for the year in which his or her
term expires and until his or her successor has been elected and qualified, subject, however, to such director's earlier death,
resignation, retirement, disqualification or removal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Unless and except to the extent that the Bylaws shall so require, the election of directors need not be
by written ballot. The holders of shares of Common Stock shall not have cumulative voting rights with regard to election of directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Subject to Section 7(g), newly created directorships resulting from an increase in the number of directors
and any vacancies on the Board resulting from death, resignation, retirement, disqualification, removal or other cause may be filled solely
and exclusively by a majority vote of the remaining directors then in office, even if less than a quorum or by a sole remaining director
(and not by stockholders), and any director so chosen shall hold office until the annual meeting for the year in which the vacancy occurred
and until his or her successor has been elected and qualified, subject, however, to such director's earlier death, resignation,
retirement, disqualification or removal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Subject to Section 7(g) and except as otherwise provided for by this Fifth Amended Certificate, any or
all of the directors may be removed from office at any time, but only for cause and only by the affirmative vote of holders of a majority
of the voting power of all then issued and outstanding shares of capital stock of the Corporation entitled to vote generally in the election
of directors, voting together as a single class.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Notwithstanding any other provision of this Section 7, and except as otherwise required by law, whenever
the holders of one or more series of the Preferred Stock shall have the right, voting separately by class or series, to elect one or more
directors, the term of office, the filling of vacancies, the removal from office and other features of such directorships shall be governed
by the terms of such series of the Preferred Stock as set forth in this Amended and Restated Certificate (including any Preferred Stock
Designation).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) A quorum for the transaction of business by the directors shall be set forth in the Bylaws.

Section 8. <u>Powers of Board</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In furtherance and not in limitation of the powers conferred by the laws of the DGCL, the Board is expressly
authorized and empowered:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To make, alter, amend, and repeal the Bylaws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Subject to the applicable provisions of the Bylaws then in effect, to determine, from time to time, whether
and to what extent, and at what times and places, and under what conditions and regulations, the accounts and books of the Corporation,
or any of them, shall be open to stockholder inspection, provided that no stockholder shall have any right to inspect any of the accounts,
books or documents of the Corporation, except as permitted by law, unless and until authorized to do so by resolution of the Board or
of the stockholders of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To authorize and issue, without stockholder consent, obligations of the Corporation, secured and unsecured,
under such terms and conditions as the Board, in its sole discretion, may determine, and to pledge or mortgage, as security therefore,
any real or personal property of the Corporation, including after-acquired property;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) To determine whether any and, if so, what part of the earned surplus of the Corporation shall be paid
in dividends to the stockholders, and to direct and determine other use and disposition of any such earned surplus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) To fix, from time to time, the amount of the profits of the Corporation to be reserved as working capital
or for any other lawful purpose;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) To establish bonus, profit-sharing, stock option, or other types of incentive compensation plans for the
employees, including officers and directors, of the Corporation, and to fix the amount of profits to be shared or distributed, and to
determine the persons to participate in any such plans and the amount of their respective participations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) to designate, by resolution or resolutions passed by a majority of the whole Board, one or more committees,
each consisting of two or more directors, which, to the extent permitted by law and authorized by the resolution or the Bylaws, shall
have and may exercise the powers of the Board; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) To provide for the reasonable compensation of its own members by Bylaw, and to fix the terms and conditions
upon which such compensation will be paid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) In addition to the powers and authority hereinbefore, or by statute, expressly conferred upon it, the
Board may exercise all such powers and do all such acts and things as may be exercised or done by the Corporation, subject, nevertheless,
to the provisions of the laws of the State of Delaware, of this Fifth Amended Certificate, and of the Bylaws of the Corporation.

Section 9. <u>Interested Directors</u>. No contract or transaction between this Corporation and any of its directors, or between this Corporation and any other corporation, firm, association, or other legal entity shall be invalidated by reason of the fact that the director of the Corporation has a direct or indirect interest, pecuniary or otherwise, in such corporation, firm, association, or legal entity, or because the interested director was present at the meeting of the Board which acted upon or in reference to such contract or transaction, or because he participated in such action, provided that: (1) the interest of each such director shall have been disclosed to or known by the Board and a disinterested majority of the Board shall have, nonetheless, ratified and approved such contract or transaction (such interested director or directors may be counted in determining whether a quorum is present for the meeting at which such ratification or approval is given); or (2) the conditions of DGCL Title 8, Section 144 are met.

Section 10. <u>Stockholder Action</u>. Any action required or permitted to be taken by the stockholders of the Corporation must be effective at a duly called annual meeting or at a special meeting of stockholders of the Corporation, unless such action requiring or permitting stockholder approval is approved by a majority of the directors, in which case such action may be authorized or taken by the written consent of the holders of outstanding shares of voting stock having not less than the minimum voting power that would be necessary to authorize or take such action at a meeting of stockholders at which all shares entitled to vote thereon were present and voted, provided all other requirements of applicable law and this Fifth Amended Certificate have been satisfied.

Section 11. <u>Special Stockholder Meetings</u>. Special meetings of the stockholders of the Corporation for any purpose or purposes may be called at any time by a majority of the Board. Special meetings may not be called by any other person or persons. Each special meeting shall be held at such date and time as is requested by Board, within the limits fixed by law.

Section 12. <u>Location of Stockholder Meetings</u>. Meetings of stockholders of the Corporation may be held within or without the State of Delaware, as the Bylaws may provide. The books of the Corporation may be kept (subject to any provision of the DGCL) outside the State of Delaware at such place or places as may be designated from time to time by the Board or in the Bylaws.

Section 13. <u>Private Property of Stockholders</u>. The private property of the stockholders shall not be subject to the payment of corporate debts to any extent whatever and the stockholders shall not be personally liable for the payment of the Corporation's debts.

Section 14. <u>Amendments</u>. The Corporation reserves the right to adopt, repeal, rescind, alter or amend in any respect any provision contained in this Fifth Amended Certificate in the manner now or hereafter prescribed by applicable law and all rights conferred on stockholders herein granted subject to this reservation.

Section 15. <u>Term of Existence</u>. The Corporation is to have perpetual existence.

Section 16. <u>Liability of Directors</u>. No director of this Corporation shall have personal liability to the Corporation or any of its stockholders for monetary damages for breach of fiduciary duty as a director or officers involving any act or omission of any such director or officer. The foregoing provision shall not eliminate or limit the liability of a director (i) for any breach of the director's duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or, which involve intentional misconduct or a knowing violation of law, (iii) under applicable sections of the DGCL, (iv) the payment of dividends in violation of the DGCL or, (v) for any transaction from which the director derived an improper personal benefit. Any repeal or modification of this Section 16 by the stockholders of the Corporation shall be prospective only and shall not adversely affect any limitation on the personal liability of a director or officer of the Corporation for acts or omissions prior to such repeal or modification.

Section 17. <u>Indemnification</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Indemnification in Actions, Suits or Proceedings other than Those by or in the Right of the Corporation*.
Subject to Section 17(c) and Section 17(j), the Corporation shall, to the fullest extent permitted by the DGCL and applicable Delaware
law as in effect at any time, indemnify, hold harmless and defend any person who: (i) was or is a director or officer of the Corporation
or was or is a director or officer of a direct or indirect wholly owned subsidiary of the Corporation, and (ii) was or is a party or is
threatened to be made a party to, or was or is otherwise directly involved in (including as a witness), any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation)
by reason of the fact that such person was or is a director or officer of the Corporation or any direct or indirect wholly owned subsidiary
of the Corporation, or was or is serving at the request of the Corporation as a director, officer, employee, partner, member or agent
of another corporation, partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise, whether
the basis of such proceeding is alleged action in an official capacity or in any other capacity, against expenses (including attorneys'
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action,
suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best
interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person's
conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea or
nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner
which such person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal
action or proceeding, had reasonable cause to believe that such person's conduct was unlawful.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Indemnification in Actions, Suits or Proceedings by or in the Right of the Corporation*. Subject
to Section 17(c) and Section 17(j), the Corporation shall indemnify, hold harmless and defend any person who: (i) was or is a director
or officer of the Corporation or was or is a director or officer of a direct or indirect wholly owned subsidiary of the Corporation, and
(ii) was or is a party or is threatened to be made a party to, or was or is otherwise directly involved in (including as a witness), any
threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of
the fact that such person was or is a director or officer of the Corporation or any direct or indirect wholly owned subsidiary of the
Corporation, or was or is serving at the request of the Corporation as a director, officer, employee, partner, member or agent of another
corporation, partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise, and whether the
basis of such action, suit or proceeding is alleged action in an official capacity or in any other capacity, against expenses (including
attorneys' fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or
suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests
of the Corporation; except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall
have been adjudged to be liable to the Corporation unless and only to the extent that the Courts in the State of Delaware or the court
in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all
the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court in the State
of Delaware or such other court shall deem proper.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Authorization of Indemnification*. Any indemnification or defense under this Section 17 (unless
ordered by a court) shall be made by the Corporation only as authorized in the specific case upon a determination that indemnification
of the director or officer is proper in the circumstances because such person has met the applicable standard of conduct set forth in
Section 17(a) or Section 17(b), as the case may be. Such determination shall be made, with respect to a person who is a director or officer
at the time of such determination: (i) by directors constituting a majority of the Board and who are not parties to such action, suit
or proceeding, even though less than a quorum (the "Board Voting Majority"), or (ii) by a committee of such directors designated
by the Board Voting Majority, even though less than a quorum, or (iii) if there are no such directors, or if such directors so direct,
by independent legal counsel in a written opinion, or (iv) by the stockholders. Such determination shall be made, with respect to former
directors and officers, by any person or persons having the authority to act on the matter on behalf of the Corporation. To the extent,
however, that a present or former director or officer of the Corporation has been successful on the merits or otherwise in defense of
any action, suit or proceeding set forth in Section 17(a) or Section 17(b) or in defense of any claim, issue or matter therein, such person
shall be indemnified against expenses (including attorneys' fees) actually and reasonably incurred by such person in connection
therewith, without the necessity of authorization in the specific case.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Good Faith Defined*. For purposes of any determination under Section 17(c), a person shall be deemed
to have acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation,
or, with respect to any criminal action or proceeding, to have had no reasonable cause to believe such person's conduct was unlawful,
if such person's action is based on good faith reliance on the records or books of account of the Corporation or another enterprise,
or on information supplied to such person by the officers of the Corporation or another enterprise in the course of their duties, or on
the advice of legal counsel for the Corporation or another enterprise or on information or records given or reports made to the Corporation
or another enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by
the Corporation or another enterprise. The term "another enterprise" as used in this Section 17(d) shall mean any other corporation
or any partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise of which such person was
or is serving at the request of the Corporation as a director, officer, employee, partner, member or agent. The provisions of this Section
17(d) shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable
standard of conduct set forth in Section 17(a) or Section 17(b), as the case may be.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Expenses Payable in Advance*. Expenses, including attorneys' fees, incurred by a current or
former director or officer in defending any action, suit or proceeding described in Section 17(a) or Section 17(b) shall be paid by the
Corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such
director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the
Corporation as authorized in this Section 17.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) *Non-exclusivity of Indemnification and Advancement of Expenses*. The indemnification, defense and
advancement of expenses provided by or granted pursuant to this Section 17 shall not be deemed exclusive of any other rights to which
those seeking indemnification or advancement of expenses may be entitled under the Certificate, any agreement, vote of stockholders or
disinterested directors or otherwise, both as to action in such person's official capacity and as to action in another capacity
while holding such office, it being the policy of the Corporation that indemnification of the persons specified in Section 17(a) or Section
17(b) shall be made to the fullest extent permitted by applicable law. The provisions of this Section 17 shall not be deemed to preclude
the indemnification of, or advancement of expenses to, any person who is not specified in Section 17(a) or Section 17(b) but whom the
Corporation has the power or obligation to indemnify under the provisions of the DGCL or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) *Insurance*. The Corporation may purchase and maintain insurance on behalf of any person who was
or is a director, officer, employee or agent of the Corporation, or a direct or indirect wholly owned subsidiary of the Corporation, or
was or is serving at the request of the Corporation, as a director, officer, employee, partner, member or agent of another corporation,
partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise against any liability asserted
against such person and incurred by such person in any such capacity, or arising out of such person's status as such, whether or
not the Corporation would have the power or the obligation to indemnify, hold harmless or defend such person against such liability under
the provisions of this Section 17.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) *Certain Definitions*. For purposes of this Section 17 references to the "Corporation"
shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed
in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors,
officers, employees or agents so that any person who was or is a director, officer, employee or agent of such constituent corporation,
or was or is serving at the request of such constituent corporation as a director, officer, employee, partner, member or agent of another
corporation, partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise, shall stand in the
same position under the provisions of this Section 17 with respect to the resulting or surviving corporation as such person would have
with respect to such constituent corporation if its separate existence had continued. For purposes of this Section 17, references to "fines"
shall include any excise taxes assessed on a person with respect of any employee benefit plan; and references to "serving at the
request of the Corporation" shall include any service as a director, officer, employee or agent of the Corporation which imposes
duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants
or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants
and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner "not opposed to the best interests of the
Corporation" as referred to in this Section 17.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) *Survival of Indemnification and Advancement of Expenses*. The indemnification, defense and advancement
of expenses provided by, or granted pursuant to, this Section 17 shall, unless otherwise provided when authorized or ratified, continue
as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors and administrators of
such a person.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) *Limitation on Indemnification*. Notwithstanding anything contained in this Section 17 to the contrary,
except for proceedings to enforce rights to indemnification and defense under this Section 17 (which shall be governed by Section 17(k)(ii)),
the Corporation shall not be obligated under this Section 17 to indemnify, hold harmless or defend any director, officer, employee or
agent in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized
by the Board. Notwithstanding anything contained in this Section 17 to the contrary, the prevailing party shall not be entitled to recover
from the other party reasonable attorneys' fees, costs and expenses incurred in connection with the prosecution or defense of such
action to the extent that such fees, costs and expenses relate to "internal corporate claims" as defined in Section 109(b)
of the DGCL

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) *Contract Rights*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The obligations of the Corporation under this Section 17 to indemnify, hold harmless and defend a person
who was or is a director or officer of the Corporation or was or is a director or officer of a direct or indirect wholly owned subsidiary
of the Corporation, including the duty to advance expenses, shall be considered a contract between the Corporation and such person, and
no modification or repeal of any provision of this Section 17 shall affect, to the detriment of such person, such obligations of the Corporation
in connection with a claim based on any act or failure to act occurring before such modification or repeal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) If a claim under Section 17(a), Section 17(b) or Section 17(e) is not paid in full by the Corporation
within 90 days after a written claim has been received by the Corporation, except in the case of a claim for an advancement of expenses,
in which case the applicable period shall be 45 days, the person making such claim may at any time thereafter bring suit against the Corporation
to recover the unpaid amount of the claim. To the fullest extent permitted by applicable law, if successful in whole or in part in any
such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, such
person shall be entitled to be paid also the expense of prosecuting or defending such suit. In (i) any suit brought by such person to
enforce a right to indemnification hereunder (but not in a suit brought by such person to enforce a right to an advancement of expenses)
it shall be a defense, and (ii) in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of
an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that such person has not met any
applicable standard for indemnification set forth in the DGCL. Neither the failure of the Corporation (including its directors who are
not parties to such action, a committee of such directors, independent legal counsel or its Stockholders) to have made a determination
prior to the commencement of such suit that indemnification of such person is proper in the circumstances because such person has met
the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Corporation (including its directors who
are not parties to such action, a committee of such directors, independent legal counsel or its Stockholders) that such person has not
met such applicable standard of conduct, shall create a presumption that such person has not met the applicable standard of conduct or,
in the case of such a suit brought by such person, be a defense to such suit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) *Indemnification Agreements*. Without limiting the generality of the foregoing, the Corporation shall
have the express authority to enter into such agreements as the Board deems appropriate for the indemnification of present or future directors
and officers of the Corporation in connection with their service to, or status with, the Corporation or any other corporation, entity
or enterprise with whom such person is serving at the express written request of the Corporation.

Section 18. <u>Forum; Consent to Jurisdiction; Severability</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery
of the State of Delaware (the "Court of Chancery") shall, to the fullest extent provided by law, be the sole and exclusive
forum for any stockholder (including a beneficial owner) to bring (i) any derivative action or proceeding brought on behalf of the Corporation,
(ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to
the Corporation or the Corporation's stockholders, (iii) any action asserting a claim against the Corporation, its directors, officers
or employees arising pursuant to any provision of the DGCL or this Amended and Restated Certificate or the Bylaws, or (iv) any action
asserting a claim against the Corporation, its directors, officers or employees governed by the internal affairs doctrine and, if brought
outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder's
counsel, except for, as to each of (i) through (iv) above, any claim (A) as to which the Court of Chancery determines that there is an
indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal
jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction
of a court or forum other than the Court of Chancery, or (C) for which the Court of Chancery does not have subject matter jurisdiction,
as to which the Court of Chancery and the U.S. federal district court for the District of Delaware shall have concurrent jurisdiction.
Notwithstanding the foregoing, the provisions of this Section 18(a) will not apply to suits brought to enforce a duty or liability created
by the Securities Exchange Act of 1934, as amended, or the rules and regulations thereunder or any other claim for which the U.S. federal
district courts have exclusive jurisdiction. Unless the Corporation consents in writing to the selection of an alternative forum, the
U.S. federal district courts shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under
the Securities Act of 1933, as amended, against the Corporation or any director, officer, other employee or agent of the Corporation.
Any person or entity purchasing or otherwise acquiring any interest in any security of the Corporation shall be deemed to have notice
of and consented to the provisions of this Section 18(a).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Consent to Jurisdiction</u>. If any action the subject matter of which is within the scope of Section
18(a) immediately above is filed in a court other than a court located within the State of Delaware (a "Foreign Action") in
the name of any stockholder, such stockholder shall be deemed to have consented to (i) the personal jurisdiction of the state and U.S.
federal district courts located within the State of Delaware in connection with any action brought in any such court to enforce Section
18(a) (an "FSC Enforcement Action") and (ii) having service of process made upon such stockholder in any such FSC Enforcement
Action by service upon such stockholder's counsel in the Foreign Action as agent for such stockholder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Severability</u>. If any provision or provisions of this Section 18 shall be held to be invalid, illegal
or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by
law, the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Section
18 (including, without limitation, each portion of any sentence of this Section 18 containing any such provision held to be invalid, illegal
or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons
or entities and circumstances shall not in any way be affected or impaired thereby. Any person or entity purchasing or otherwise acquiring
any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Section
18. Section 19. <u>Corporate Opportunity</u>. To the extent allowed by law, the doctrine of corporate opportunity, or any other analogous doctrine, shall not apply with respect to the Corporation or any of its officers or directors, or any of their respective affiliates, in circumstances where the application of any such doctrine would conflict with any fiduciary duties or contractual obligations they may have as of the date of this Fifth Amended Certificate or in the future, and the Corporation renounces any expectancy that any of the directors or officers of the Corporation will offer any such corporate opportunity of which he or she may become aware to the Corporation, except, the doctrine of corporate opportunity shall apply with respect to any of the directors or officers of the Corporation with respect to a corporate opportunity that was offered to such person solely in his or her capacity as a director or officer of the Corporation and (i) such opportunity is one the Corporation is legally and contractually permitted to undertake and would otherwise be reasonable for the Corporation to pursue and (ii) the director or officer is permitted to refer that opportunity to the Corporation without violating any legal obligation.

Section 20. <u>Headings</u>. The headings contained herein are for convenience only, do not constitute a part of this Fifth Amended Certificate and shall not be deemed to limit or affect any of the provisions hereof.

IN WITNESS WHEREOF, the undersigned has executed this Fifth Amended Certificate as of June __, 2025.

---

| |
|:---|
| SBC Medical Group Holdings Incorporated |
| By: |
| Name: |
| Title: |

---